# Acuity of asthma exacerbations in Alberta, Canada is increasing: a population-based study

**Authors:** Adil Adatia, Jalal Moolji, Imran Satia

PMC · DOI: 10.1186/s13223-024-00872-0 · Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology · 2024-02-12

## TL;DR

Asthma exacerbations in Alberta are becoming more severe despite fewer emergency visits, suggesting a need for further investigation into worsening severity.

## Contribution

This study provides population-level evidence of increasing acuity of asthma exacerbations in Alberta from 2010 to 2022.

## Key findings

- The mean number of ED visits for asthma decreased from 4.5 to 2.2 per million persons per day.
- The acuity of asthma exacerbations and hospitalization rates increased significantly during the study period.
- Patients presenting with the highest acuity increased by over 300%.

## Abstract

Asthma is a common respiratory illness affecting 2.8 million Canadians, including 9.7% of Albertans. Prior studies showed a substantial decrease in ED visits for asthma in the decade preceding 2010, followed by a stabilization. This was attributed to improvements in the pharmacologic and non-pharmacologic treatments for asthma during that period followed by a balance between epidemiologic drivers and protective factors in the population.

We assessed whether this trend continued in Alberta from 2010 to 2022 using population level data for the volume of daily ED visits, acuity of asthma exacerbations in the ED, and hospitalization rate.

The mean number of ED visits decreased from 4.5 to 2.2 per million persons per day, but the acuity of exacerbations and the proportion requiring hospitalization increased. The number of patients presenting with the highest level of acuity increased by over 300%, and the percentage of patients requiring hospitalization increased from 6.8 to 11.3%.

Total ED visits for asthma exacerbations continues to decline in Alberta. The reasons for an increase in more severe exacerbations requires further attention.

The online version contains supplementary material available at 10.1186/s13223-024-00872-0.

## Linked entities

- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Diseases:** Asthma (MESH:D001249), respiratory illness (MESH:D012140)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10863092/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10863092/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC10863092/full.md

---
Source: https://tomesphere.com/paper/PMC10863092